Form 4: Glaukos Corp Executive Joseph E. Gilliam Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares on May 6, 2024, according to a Form 4 filing with the SEC.
Summary
- On May 6, 2024, Joseph E. Gilliam, the President & COO of Glaukos Corporation, exercised stock options to acquire 105 shares of common stock at a price of $55.18 per share.
- Simultaneously, Gilliam sold 105 shares of Glaukos common stock at a price of $110.36 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2023.
- Following these transactions, Gilliam directly owns 101,845 shares of Glaukos common stock, which includes 76,419 restricted stock units that have not yet vested.
- He also holds options to purchase 40,634 shares of common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports routine transactions under a pre-existing trading plan. There is no indication of positive or negative sentiment towards the company's prospects.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
Industry Context
Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are a common tool used by corporate insiders to sell shares while avoiding accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 2022/03/24 | Date of original grant of stock options, vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. |
| 2023/03/07 | Date the Reporting Person adopted a Rule 10b5-1 trading plan. |
| 2024/05/06 | Date of stock option exercise and sale. |
| 2024/05/08 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.